Indian Journal of Gastroenterology

, Volume 32, Issue 1, pp 3–17

Pancreatic neuroendocrine tumors

Authors

    • Gastrointestinal and Hepato-Pancreato-Biliary Surgical Oncology, Tata Memorial Centre
  • Bhawna Sirohi
    • Medical and Hemato-Oncology, Artemis Health Sciences
  • Mahesh Goel
    • Gastrointestinal and Hepato-Pancreato-Biliary Surgical Oncology, Tata Memorial Centre
  • Savio G. Barreto
    • Gastrointestinal and Hepato-Pancreato-Biliary Surgical Oncology, Tata Memorial Centre
REVIEW ARTICLE

DOI: 10.1007/s12664-012-0257-2

Cite this article as:
Shrikhande, S.V., Sirohi, B., Goel, M. et al. Indian J Gastroenterol (2013) 32: 3. doi:10.1007/s12664-012-0257-2

Abstract

Pancreatic neuroendocrine tumors (pancreatic NETs) are rare, low- to intermediate-grade neoplasms thought to arise from the pancreatic islets. Recent advances in pathology and our understanding of the biological behavior of this group of tumors has resulted in changes in their nomenclature and how we treat them. This review puts into perspective our current understanding of pancreatic NETs in terms of their incidence, pathology, and management.

Keywords

ChemoembolizationGlucagonInsulinSomatostatin

Copyright information

© Indian Society of Gastroenterology 2012